Answers are grounded in this paper and cite their sources.
Circulating damage-associated molecular patterns (DAMPs) are associated with injury and adverse outcomes in sepsis, but their concentrations do not identify their cellular origins or rates of release. This narrative review compares nuclear cell-free DNA, mitochondrial DNA, HMGB1, extracellular histones, nucleosomes, ATP, heat shock proteins, extracellular RNA, and NAD+, with attention to source specificity, extracellular persistence, and assay limitations. Human methylation studies identify leukocyte and parenchymal contributions to nuclear cell-free DNA, while experimental models demonstrate that nonhematopoietic contributions can emerge alongside ongoing hematopoietic release. These findings motivate a temporal framework in which leukocyte activation, endothelial injury, and parenchymal injury overlap. Their order and relative contributions remain hypotheses that may differ among patients and mediators. Degradation, clearance, and redistribution also shape the measured circulating pool. We distinguish experimental mechanisms from clinical associations and propose serial sampling anchored to sepsis recognition, accompanied by organ function and coagulation assessments. Source-resolved measurements may support prognostic assessment and trial stratification, but their incremental value and ability to predict treatment response require prospective validation. A DAMP concentration should therefore be interpreted together with sampling time, molecular form, and clinical context.
No takes yet. Share an insight, caveat, or question.
Iba et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: